Receiving a $47M payment for the first order of 5M working GenViro kits is a great start to helping to build up their blood glucose test strip presence. DECN could easily get the TBG technology fully patented and approved with that kind of money.
(4)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links